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OBJECTIVE—Curing type 1 diabetes by transplanting pancre-
atic islets into the liver is associated with poor long-term
outcome and graft failure at least partly due to inadequate graft
revascularization. The aim of the current study was to evaluate
striated muscle as a potential angiogenic site for islet
transplantation.
RESEARCH DESIGN AND METHODS—The current study
presents a new experimental model that is found to be applicable
to clinical islet transplantation. Islets were implanted into stri-
ated muscle and intraislet vascular density and blood ﬂow were
visualized with intravital and confocal microscopy in mice and by
magnetic resonance imaging in three autotransplanted pancrea-
tectomized patients. Mice were rendered neutropenic by re-
peated injections of Gr-1 antibody, and diabetes was induced by
alloxan treatment.
RESULTS—Contrary to liver-engrafted islets, islets transplanted
to mouse muscle were revascularized with vessel densities and
blood ﬂow entirely comparable with those of islets within intact
pancreas. Initiation of islet revascularization at the muscular site
was dependent on neutrophils, and the function of islets trans-
planted to muscle was proven by curing diabetic mice. The
experimental data were conﬁrmed in autotransplanted patients
where higher plasma volumes were measured in islets engrafted
in forearm muscle compared with adjacent muscle tissue
through high-resolution magnetic resonance imaging.
CONCLUSIONS—This study presents a novel paradigm in islet
transplantation whereby recruited neutrophils are crucial for the
functionally restored intraislet blood perfusion following trans-
plantation to striated muscle under experimental and clinical
situations. Diabetes 59:2569–2578, 2010
T
ransplantation of pancreatic tissue is today the
only curative treatment for type 1 diabetes.
Clinically, either the entire pancreas is trans-
planted into the abdominal cavity or isolated
insulin producing islets of Langerhans are implanted into
the liver through infusion via the portal vein. The former
procedure is highly successful; the graft functions well
following transplantation. However, it requires extensive
surgery, whereas the latter procedure is attractive because
only minor surgery is required in conscious recipients.
Unfortunately, both function and survival of intrahepati-
cally transplanted islets deteriorate with time (1). Delayed
and insufﬁcient islet revascularization (2), gluco- and
lipotoxicity (3), presence of an instant blood-mediated
inﬂammatory reaction (4,5), and toxicity of the immuno-
suppressive drugs present in high concentrations in the
portal blood (6,7) are all factors believed to contribute to
graft failure at this site.
Native islets are highly vascularized, with blood perfu-
sions ten times higher than in the exocrine pancreas (8,9).
The islet microvasculature consists of a dense glomerular-
like capillary network. A speciﬁc perfusion order of the
different endocrine cell types has been shown in islets of
Langerhans (10–15), enabling intraislet cell communica-
tion and further demonstrating the importance of a reﬁned
and adequate intraislet blood ﬂow for normal islet
function.
Many of the factors contributing to poor islet function
are associated with the liver as the site for engraftment
(3,5,6,16,17), and for this reason other sites are now being
investigated. The intramuscular site has attracted recent
interest as a result of positive long-term outcome of
autotransplantation of parathyroid glands to the brachi-
oradialis muscle (18). Indeed, in a recent case report, we
documented a successful 2-years follow-up of a child
receiving autotransplanted islets into muscle (19).
Myeloid-derived leukocytes have recently been shown
to be involved in muscle healing and regeneration includ-
ing angiogenesis (20,21); we therefore hypothesized that
leukocytes may also be involved in the engraftment and
revascularization of transplanted islets to muscle. To
address this hypothesis, in addition to evaluation of stri-
ated muscle as a potential angiogenic site for islet trans-
plantation, an in vivo mouse model was developed that
enables studies of leukocyte–endothelial cell interactions
and blood ﬂow during revascularization of transplanted
From the
1Department of Medical Cell Biology, Uppsala University, Uppsala,
Sweden; the
2Department of Oncology, Radiology and Clinical Immunology,
Uppsala University, Uppsala, Sweden; the
3Department of Genetics and
Pathology, Uppsala University, Uppsala, Sweden; the
4Department for
Clinical Science, Intervention and Technology, Karolinska Institutet, Stock-
holm, Sweden; and the
5Department of Medical Sciences, Uppsala Univer-
sity, Uppsala, Sweden.
Corresponding author: Mia Phillipson, mia.phillipson@mcb.uu.se.
Received 10 February 2010 and accepted 8 July 2010. Published ahead of
print at http://diabetes.diabetesjournals.org on 22 July 2010. DOI:
10.2337/db10-0205.
© 2010 by the American Diabetes Association. Readers may use this article as
long as the work is properly cited, the use is educational and not for proﬁt,
and the work is not altered. See http://creativecommons.org/licenses/by
-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
ORIGINAL ARTICLE
diabetes.diabetesjournals.org DIABETES, VOL. 59, OCTOBER 2010 2569islets by intravital and confocal microscopy. Long-term
islet function and survival following transplantation to
muscle were evaluated in diabetic recipients. The results
achieved in the experimental model were thereafter vali-
dated in patients receiving islets autotransplanted to mus-
cle following pancreatectomy with a sophisticated
magnetic resonance imaging technique.
RESEARCH DESIGN AND METHODS
Male C57Bl/6 mice (25–30 g ([B&K Universal]) and C57Bl/6 nu/nu mice (25–30 g
[Taconic M&B]) were used. Experiments were approved by the Uppsala Labora-
tory Animal Ethical Committee. An online appendix describes additional
methods (http://diabetes.diabetesjournals.org/cgi/content/full/db10-0205/DC1).
Islet isolation and transplantation to mice. Mouse islets of Langerhans
were isolated and cultured over night as previously described (22). Human
islets from ﬁve heart-beating female donors (age 57  7 years) were isolated
and cultured as previously described (23). Islets were ﬂuorescently labeled
immediately before transplantation with the intracellular probes Celltracker
Blue CMAC or Celltrace Far Red DDAO (Invitrogen), depending on the type of
imaging performed later. For transplantation into the cremaster muscle
(surrounding the testis) of nondiabetic mice, 5–20 islets in suspension were,
by the use of a butterﬂy needle (25G), repeatedly injected subfascially at
different spots to allow for single islet engraftment. For transplantation to the
liver of nondiabetic mice, 200 islets were infused via the portal vein.
Diabetic mice (injected with 75 mg/kg i.v. alloxan; Sigma-Aldrich) had
plasma glucose concentrations of 25.8  1.0 mmol/l on the day of transplan-
tation. A suspension with 300 islets was injected superﬁcially between
abdominal external oblique muscle ﬁbers (on the side of the abdomen) or
infused into the portal vein to the liver. Plasma glucose levels 11.1 mmol/l
were deemed normalized, and mice were killed if blood glucose levels were
20 mmol/l 7 days posttransplantation.
Intravital microscopy. The cremaster muscles of isoﬂurane-anaestetized
(Abbott) mice with implanted islets were prepared for intravital microscopy
as previously described (24). A catheter in the femoral artery allowed
retrograde infusion close intra-arterially to the muscle. An intravital micro-
scope (Leica Microsystems DM5000B equipped with a Hamamatsu Orca-R2
CCD camera and HCX Apo L 20/0.50W and 40/0.80W objectives; Volocity
software) was used to visualize the microcirculation of transplanted islets and
surrounding muscle. Recordings were made for analysis of adherent (station-
ary for 30 s within 100 m length of venule in 3 min) and emigrated
leukocytes (cells in the extravascular space per ﬁeld of view [0.05 mm
2]).
Laser scanning confocal microscopy (Nikon C-1 with Plan Fluor ELWD
20/0.45 and 40/0.60 objectives; Nikon EZ-C1 software), spinning disk
confocal microscopy (Olympus BX51/Quorum WaveFx with a Hamamatsu
C9100-13 EMCCD camera and an XLUM Plan F1 20/0.95W objective;
Volocity software), or multiphoton microscopy (Olympus FV300/Chameleon
ti:sapphire laser with a 40/0.80W objective and Olympus FluoView and
ImageJ software or Zeiss 710 NLO with a Plan-Apo 20/1.0W objective; Zeiss
Zen software) was performed after intra-arterial injection of 25 g Alexa Fluor
555 or 594 anti–CD31 monoclonal antibody (mAb) (clone 390; eBioscience) to
stain endothelium and 15 g ﬂuorescein isothiocyanate (FITC) anti–Gr-1 mAb
(clone RB6–8C5; eBioscience) to stain neutrophils.
Vessel density and functionality. Parafﬁn sections of transplants were
stained for insulin with anti-insulin antibody (Fitzgerald) and for endothelium
with the lectin Bandeiraea simplicifolia-1 (BS-1) (Sigma-Aldrich) (supplemen-
tal Figs. 1 and 2). Vessel functionality within grafts was studied through
intrajugular injection of 100 g soybean agglutinin (SBA) lectin, which stains
endothelium and allows for detection of perfused vessels. Endothelium was
stained in cryosections with anti-CD31 mAb (conjugated to Alexa Fluor 555),
and nuclei were stained with Hoechst 33342 (Invitrogen).
Neutrophil depletion. Mice were rendered neutropenic by intraperitoneal
injections of anti–Gr-1 (clone RB6-8C5; eBioscience). Immunoglobulin G (IgG)
isotype antibody (eBioscience) was injected in controls. One day prior to
transplantation (day zero), 150 g was injected; an additional 150 g was
injected on day three. Determination of treatment efﬁciency was made by
blood analysis and differential count. Total leukocyte counts were reduced by
50% (8.2  1.0  10
9/l vs. 4.1  0.6  10
9/l), and neutrophil counts were
reduced by 80% (19.2  5.2  10
8/l vs. 4.2  1.2  10
8/l). No Gr-1–postive cells
were found nearby the grafts in Gr-1 antibody–treated animals.
Clinical intramuscular islet autotransplantation. The study was ap-
proved by the Regional Ethics Board, Uppsala, Sweden, and was performed in
accordance with local institutional and Swedish national rules and
regulations.
Three patients (two men and one woman) with intraductal papillary
mucinous neoplasm underwent total pancreatectomy with a Whipple proce-
dure and autologous intramuscular islet transplantation (Table 1). Ex vivo the
pancreas was immediately perfused with cold (4°C) University of Wisconsin
solution and shipped to the islet isolation laboratory of the Nordic Network
for Clinical Islet Transplantation (cold ischemic time 2 hours). Islet isolation
was performed as previously described (23), and islets were maintained in
culture for 24 h before characterization (supplemental Table 1).
Absence of functioning endocrine pancreatic tissue before islet transplan-
tation was conﬁrmed in all patients by lack of C-peptide (Table 1) (25). Under
brachial plexus anesthesia, islets in volumes of 50–100 l were injected into
the muscle ﬁbers of the brachioradialis muscle (in the forearm) with the help
of a central venous catheter (Secalon-T, 16G, 130 mm; BD Biosciences). Islet
graft function after transplantation was assessed by circulating C-peptide
(Table 1).
The subjects were scanned 3–6 months posttransplantation using a 1.5 T
clinical magnetic resonance scanner (Gyroscan Intera; Philips Medical Sys-
tems). The body coil was used for radio frequency transmission and a 45-mm
circular linear coil for radio frequency reception. High-resolution axial images
were obtained using a T1-weighted three-dimensional gradient echo acquisi-
tion with 32 slices, (in-plane resolution of 200  200 m
2 and a slice thickness
of 1.0 mm; TR/TE/ﬂip 16/5/10).
Statistics. Data are means  SEM. Paired and unpaired two-tailed Student t
tests were used to compare between groups.
RESULTS
This study used a novel experimental model where iso-
lated pancreatic islets are transplanted into the mouse
cremaster muscle for ease of visualization. The reestab-
lished circulation to the transplanted tissue was studied by
transillumination, epiﬂuorescence, spinning disk, laser
scanning confocal and multiphoton microscopy, and the
functionality of intramuscularly engrafted islets was tested
in diabetic recipients. For translational purposes, ultra-
high resolution magnetic resonance imaging was per-
formed on autotransplanted islets engrafted in the
brachioradialis muscle of patients in order to evaluate islet
revascularization through measurements of plasma vol-
ume in transplanted islets versus surrounding muscle
tissue.
TABLE 1
Islet characterization and patient metabolic status before and
after the operation and after transplantation and islet
characterization
Subject 1 Subject 2 Subject 3
Preoperation
A1C (%) 6.7 5.0 6.1
F-PG (mmol/l) 6.6 6.6 5.4
Stimulated CP (ng/ml) 0.90 3.60 6.30
Postoperation
Stimulated CP (ng/ml) 0.12 0.12 0.12
Islet isolation
Islet yield (%) 286,957 202,174 250,435
Purity (%) 80 26 32
Volume (l) 825 2,725 1,800
Stimulation index
(16.7/1.67 mmol/l) 11.8 25 25
Content (ng/ng DNA) 9.945 0.541 0.743
ADP/ATP ratio 0.050 0.050 0.060
Posttransplantation
A1C (%) 7.9 8.0 7.0
F-PG (mM) 7.4 9.3 9.7
Insulin needs
(IU/kg body wt) 0.45 0.51 0.62
Basal CP (ng/ml) 0.39 0.12 0.12
Stimulated CP (ng/ml) 1.32 0.45 0.39
CP, C-peptide; F-PG, fasting plasma glucose; IE, islet equivalent.
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transplantation to striated muscle. Islets syngeneically
transplanted to the cremaster muscle of nondiabetic mice
rapidly became vascularized and showed functional in-
traislet blood vessels already at 3–5 days after transplan-
tation, as conﬁrmed by close intra-arterial injection of
ﬂuorescently labeled anti-CD31 mAb (Fig. 1A), with a
vessel density of 407  94 vessels/mm
2 (Fig. 1D). Follow-
ing these early events, the vasculature continued to de-
velop and, 2 weeks after transplantation, had the
characteristic glomerular-like vascular network (Fig. 1B)
seen in native islets (Fig. 1C). Two to four weeks post-
transplantation, intraislet vascular densities had increased
threefold (1,187  187 and 1,162  120 vessels/mm
2,
respectively) and were similar to those observed in islets
in intact pancreas (1,074  174 vessels/mm
2) (Fig. 1D).
Imaging of islet vasculature with deeply penetrating mul-
tiphoton microscopy 2 weeks posttransplantation revealed
a complete vascular network throughout the islet (supple-
mental Video 1). When intraislet vessel densities were
analyzed in islets transplanted intraportally to the liver of
nondiabetic mice, vessels surrounding the whole islets
were detected but no intraislet vessels could be found 2 or
4 weeks after transplantation (n  7 mice) (supplemental
Fig. 1). Transplanted islets at both sites stained positive
for insulin (supplemental Fig. 1). The intraislet capillary
diameter was enlarged 3–5 days posttransplantation to
muscle but was normalized to diameters found in islets in
intact pancreas after 2 weeks (Fig. 1E) as previously
reported (26).
High vascular densities after human islet transplan-
tation to mouse striated muscle. To investigate
whether the improved vascularization of mouse islets
transplanted to muscle also applied to human islets,
human islets were implanted into the cremaster muscle of
immune incompetent mice (nu/nu). For logistic reasons,
the human islets were cultured for an average of 4 days
prior to transplantation and, for comparison, mouse islets
were also cultured for an equal period of time. Four weeks
posttransplantation, human islets were highly vascularized
with an intraislet vascular density comparable with that of
cultured mouse islets (Fig. 1F). Intravital and confocal
microscopy showed functional vessels in transplanted
human islets, although the vessel structure was somewhat
different than that observed for transplanted mouse islets:
intraislet capillary diameters were more heterogeneous
(9–20 m) and had a differently organized, less glomeru-
lar-like vasculature (Fig. 1G and supplemental Video 2)
than that observed in mouse islets (Fig. 1B and C). The
number of remnant endothelial cells has been reported to
decrease with time in culture (27). However, the vascular
densities of mouse islets cultured for 4 days were not
signiﬁcantly lower compared with mouse islets cultured
overnight (942  50 and 1,162  120 vessels/mm
2, respec-
tively) (Fig. 1D and F), suggesting that the decreased
number of remnant donor endothelial cells does not affect
the vascularization 4 weeks after transplantation.
Functionally restored vessels after islet transplanta-
tion to striated muscle. The functionality of the newly
formed vessels within transplanted islets was investigated
by intravenous injections of ﬂuorescent SBA lectin (Fig.
2A and B), which ensures endothelial staining of perfused
vessels only. After termination of experiments, muscle
cryosections were stained for endothelial cells with anti-
CD31 mAb and the numbers of lectin- and CD31-positive
vessels were analyzed. In islets transplanted to striated
muscle and in islets in the intact pancreas, close to 100% of
the CD31-positive vessels were also positive for lectin
(Fig. 2C–E), indicating that nearly all vessels were indeed
perfused. Contrary, the very few CD31-positive cells that
could be found within islets transplanted to liver showed
low staining overlap with intravenously administered lec-
tin, suggesting mainly nonfunctional vessels, i.e., possibly
remnant donor endothelial cells (Fig. 2F).
Blood ﬂow organization in transplanted mouse and
human islets. In rodents, the -cell core of the islet
receives blood before the endocrine cell types in the islet
mantle: the -, 	- and PP-cells (i.e., --	 blood ﬂow
pattern) (14,28). To investigate the blood ﬂow pattern
following transplantation to muscle, ﬂuorescently labeled
dextran was injected close intra-arterially and islet blood
ﬂow was recorded by epiﬂuorescence microscopy. Indeed,
4 weeks after transplantation, mouse islets in muscle were
perfused from the core outwards because the ﬂuorescent
signal was initially observed in the central part of the islet
(supplemental Fig. 3A, C, and E). This indicates that
transplantation and revascularization of islets at the intra-
muscular site do not change the inherent perfusion
pattern.
Contrary to the mouse islet organization described
above, human islets have a differently organized distribu-
tion of endocrine cells throughout the islet with cluster-
ized subunits (29–32). Blood ﬂow recordings of human
islets transplanted to the cremaster muscle of nu/nu mice
during ﬂuorescent dextran injections revealed a differently
organized perfusion pattern (4 weeks posttransplantation
[supplemental Fig. 2B, D, and F]). While the blood perfu-
sion of mouse islets was directed from the core and
outward, human islets were observed to be perfused from
one side to the other in a more polarized manner and no
core-to-mantle perfusion could be detected. This implies
that the blood ﬂow of pancreatic islets differs between
species and that the inherent organization of different
endocrine cell types within the islet inﬂuences revascular-
ization and thereby gives the perfusion order.
Increased leukocyte-endothelial cell interactions in
grafts. Syngeneic transplantation is not associated with
acquired immune cell activation or concomitant graft
rejection because donor and recipient share the same
genetic background. However, intravital microscopy of
newly formed vasculature in these grafts exposed inter-
actions between circulating leukocytes and endothelial
cells within the islet capillaries and in the venules
draining the islets but not at sites receiving sham
injections of islet culture medium. Signiﬁcantly more
leukocytes adhered in venules draining islets compared
than in venules draining adjacent muscle tissue 3–5 days
posttransplantation (Fig. 3A), and emigrated leukocytes
were found in the perivascular tissue in the proximity of
recently transplanted islets (Fig. 3B). In vivo ﬂuorescent
staining of leukocytes with an acute injection of low-
dose anti–Gr-1 mAb intra-arterially revealed that the
majority of recruited leukocytes were Gr-1–positive
leukocytes (Fig. 3C). The number of recruited leuko-
cytes decreased with time after transplantation, indicat-
ing a role of leukocyte recruitment during the initial
stages of reestablishment of circulation (Fig. 3B). Gr-1–
positive leukocytes have been shown to be involved in
muscle healing and regeneration (20,21); we therefore
investigated their involvement in the revascularization
of transplanted islets. Transplantation of islets to neu-
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FIG. 1. Islets transplanted to mouse muscle revascularize rapidly and completely. A: Three to ﬁve days after transplantation, islets in the cremaster
muscle have functional intraislet blood vessels: confocal image of a mouse islet (blue; Celltracker) in the cremaster muscle 5 days posttransplantation
(post-tx), with ingrowing blood vessels (red; anti–CD31-mAb perfused intra-arterially in vivo). B: Two weeks after transplantation, a dense,
glomerular-like vascular system developed: multiphoton microscopy image of the vasculature of a transplanted mouse islet in muscle (anti–CD31-mAb).
C: The vascular density and architecture were, at 2 and 4 weeks posttransplantation, comparable with native islets in the pancreas: spinning disk
confocal image of islet vasculature in mouse pancreas (anti–CD31-mAb). D: Vessel density in islets transplanted into mouse muscle at 3–5 days (n 
4), 2 weeks (n  4), and 4 weeks (n  6) after transplantation compared with the density observed in islets in intact pancreas (n  4). Islets
transplanted into the liver did not have any intraislet vessels at these time points (n  7). E: Intraislet capillary diameter of transplanted mouse islets
is increased shortly after transplantation (3–5 days; n  5, 3 capillaries/islet) but reaches values comparable with native islet capillaries (n  3, 3
capillaries/islet) at 2 weeks posttransplantation (n  4, 3 capillaries/islet). F: The vascular densities of human islets transplanted to mouse muscle (n 
4) were at the same high level as mouse islets cultured for the same number of days (n  3). G: Human islets transplanted to muscle of nu/nu mice had a
well-developed intraislet vascular system 4 weeks after transplantation: multiphoton microscopy image of human islet vasculature (anti–CD31-mAb). All
values are given as means  SEM. Bars in A, B, C, and G are 50 m. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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cularization of islets 3–5 days posttransplantation (Fig.
3D and E), and no intraislet vessels could be detected.
Alloxan-induced diabetes is reversed by islets trans-
plantation to muscle or liver, but only muscle en-
grafted islets show an unaffected response to glucose
load. To investigate the ability of islets transplanted to
muscle to regulate blood glucose, recipient mice were
rendered diabetic through alloxan treatment, resulting
in plasma glucose levels of 25.8  1.0 mmol/l. Thereaf-
ter, 300 islets were either transplanted into the abdom-
inal external oblique muscle (n  8) or into the liver
(n  6). There was not a difference in time to normal-
ization of blood glucose levels between the two sites;
both groups were below 11.1 mmol/l at just over 1 week
posttransplantation (Fig. 4A). Three mice with plasma
glucose levels 20 mmol/l 1 week posttransplantation
were killed because of ethical requirements (two with
grafts in muscle and one with grafts in the liver). Plasma
glucose levels in the successful recipients remained
11.1 mmol/l for at least 2 months. Islet functionality
was tested by an intraperitoneal glucose tolerance test.
Animals with islets transplanted to muscle did not
signiﬁcantly differ in glucose handling from nondiabetic
control mice, but animals with islets transplanted to
liver had a signiﬁcant delay in lowering blood glucose
after glucose load (Fig. 4B), resulting in an increased
area under the curve (Fig. 4C). Islets transplanted to the
abdominal external oblique muscle of diabetic mice had
vascular densities similar to those of islets transplanted
to the cremaster muscle of nondiabetic mice (967  65
vs. 1,162  120 vessels/mm
2) (Fig. 4D). Insulin staining
of pancreata after termination of experiments conﬁrmed
maintained low densities of -cells in all alloxan-treated
mice, excluding the possibility of normalization of blood
glucose levels due to -cell regeneration. The intramus-
cular site was visualized 3 days after transplantation of
ﬂuorescently labeled islets through IVIS imaging (Fig.
4E).
Autotransplanted islets to striated muscle of pancre-
atectomized patients exhibit higher blood ﬂow
compared with adjacent muscle tissue. Three pancre-
atectomized patients receiving autotransplantation of iso-
lated islets to the brachioradialis muscle were scanned
using magnetic resonance imaging 3–6 months after sur-
gery. The MRI technique used yields a very high in-plane
resolution of 200 m in vivo (33), which is required to
accurately visualize the islet grafts. Islets could indeed be
detected in muscle tissue at the site of injection in all three
patients (Fig. 5A, C, E, and F and supplemental Fig. 5).
Therefore, fractional plasma volume, which corresponds
to capillary density of the scanned area, was investigated
through kinetic modeling. In two of the subjects, the
capillary density was assessed through dynamic contrast
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FIG. 2. Newly formed vessels in islets transplanted to cremaster muscle are functional. A:
Confocal image of the vasculature of one small and one larger SBA lectin–perfused mouse
islet in muscle. B: Confocal image of the vasculature of an SBA lectin–perfused mouse
islet in intact pancreas. C: Functionality of newly formed islet vasculature was evaluated
by injections of ﬂuorescent endothelium–binding SBA lectin and quantiﬁed as percentage
of lectin-positive vessels over CD31-positive vessels. SBA lectin (green) was found to
overlap with anti–CD31-mAb (red) staining on cryosections in islets (dashed lines)
transplanted to muscle (n  5, 11 islets) (blue, nuclei, Hoechst 33342) (D) and in native
islets (n  4, 7 islets) (E). Islets transplanted to the liver (n  4, 8 islets) had no
functional intraislet vessels (F). All values are given as means  SEM. Bars in A, B, D, E,
and F are 50 m. post-tx, posttransplantation. (A high-quality digital representation of
this ﬁgure is available in the online issue.)
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volume, and was found to be 2.5 and 3.4 times higher in the
implanted clusters of islets compared with the surround-
ing muscle tissue. The center of the larger islet grafts (Fig.
5C and D) had a nonperfused area, which most likely
corresponds to central ﬁbrosis due to a too-large volume
of islets implanted at the same site. Hepatic steatosis has
been reported following islet transplantation to the liver
(34,35), but no focal lipid accumulation surrounding the
muscle-implanted grafts in the ﬁrst two subjects could be
detected (Fig. 5A and C). Even when high-resolution
morphological imaging on the third subject was used, no
lipid deposits could be detected close to engrafted islets
(Fig. 5E and F).
DISCUSSION
Transplantation of isolated pancreatic islets to patients
suffering from diabetes is limited by loss of function of the
grafts, which appears to be related to the site of engraft-
ment (36) including poor revascularization of the islets
(17). In the present study we report that vasculature within
islets engrafted in striated muscle are functionally and
morphologically restored within 2 weeks of transplanta-
tion. The results were obtained using intravital and confo-
cal microscopy and by immunohistochemical evaluation
and curative transplantations of diabetic mice. Initiation of
revascularization was dependent on Gr-1–positive leuko-
cytes recruited to the implantation site; no revasculariza-
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FIG. 3. Islet revascularization in muscle is dependent on neutrophils. A: Leukocyte adhesion in venules from mouse cremaster muscle. Three to
ﬁve days posttransplantation (post-tx), more adherent leukocytes were found in venules draining islets (n  5) than in venules draining only
muscle tissue (n  5); *P  0.049. B: Leukocyte emigration in the proximity of the transplanted islet was increased at 3–5 days
posttransplantation (n  5) compared with 4 weeks posttransplantation (n  5); *P  0.042. C: Confocal image of a transplanted mouse islet
(blue; Celltracker) 4 days after transplantation to a mouse treated with IgG isotype control antibody, with ingrowing blood vessels (red;
anti–CD31-mAb given intra-arterially in vivo) surrounded by leukocytes (green, anti–Gr-1-mAb, given intra-arterially in vivo) in the peritrans-
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(A high-quality digital representation of this ﬁgure is available in the online issue.)
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depletion of this leukocyte subset. Ultimately, an in-
creased capillary density was detected in islet grafts
compared with adjacent tissue in pancreatectomized pa-
tients with isolated islets autotransplanted to muscle using
an ultra-high resolution acquisition technique that was
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This technique enables registration of plasma volumes
proportional to capillary densities in small superﬁcial,
graft-containing tissue fractions corresponding to trans-
planted islets. In addition to verifying the experimental
observations, this technique will be instrumental during
our forthcoming development and evaluation of clinical
islet transplantations to the promising muscle site.
Pancreatic islets are highly organized miniature organs
with the primary function of regulating blood glucose
levels through efﬁcient sensing of present blood glucose
concentration and concomitant release of the appropriate
hormone (i.e., insulin and glucagon) from each specialized
cell type. Justiﬁably, high blood perfusion and minimal
diffusion barriers between the blood, the sensor, and the
hormone-releasing cells are prerequisites for efﬁcient
blood glucose control (8,9). During isolation, all vascular
connections to the islets are interrupted and, contrary to
solid organ transplantations, are not reconnected during
surgery. Transplanted islets therefore depend completely
on revascularization to occur. When islets are grafted into
the liver, blood vessels surround the islets but few pene-
trate the islets (2,17) (supplemental Fig. 1), which may
explain the poor long-term function of the grafts. Experi-
mental islet transplantation to other commonly used im-
plantation sites such as the kidney and spleen also results
in impaired revascularization (2). Indeed, the present
study—where islets were engrafted into striated muscle—
reports, for the ﬁrst time, islet vascular density, vessel
morphology, and blood perfusion equal to that of islets in
the intact pancreas. These ﬁndings were not restricted to
the cremaster muscle but could also be seen in islets
transplanted to abdominal external oblique, gluteal, and
psoas muscles (Fig. 4D and supplemental Fig. 4). In
addition, the experimental data were conﬁrmed in auto-
transplanted patients where higher plasma volumes were
measured in islets engrafted in forearm muscle compared
with adjacent muscle tissue, indirectly demonstrating
higher capillary densities in the grafts compared with
muscle. Hepatic steatosis of tissue surrounding the grafts
has been reported following islet transplantation to the
liver (34,35) due to paracrine insulin effects on adjacent
tissue. In the present study, no fat deposits could be
detected after autotransplantation to muscle of pancrea-
tectomized patients.
Striated muscle has successfully been used for auto-
transplantation of parathyroid glands, where these endo-
crine glands engraft and become vascularized (18). Muscle
has also been investigated under experimental settings as
a site for pancreatic islet transplantation but with varied
success (37–39). The variations in outcome may relate to
the techniques used to implant the islets. Indeed, the
negative inﬂuence of large clusters of islets were evident
in the pancreatectomized patients receiving autotrans-
planted islets to striated muscle: ﬁbrosis could be detected
in the center of large number of islets grouped together. In
the experimental part of this study, a small volume of 300
nonpacked islets was injected superﬁcially into abdominal
muscle in a pearls-on-a-string fashion (39). This resulted in
a complete cure of diabetic mice within approximately 8
days following transplantation.
The increased revascularization of islets engrafted in
muscle observed in the present study might be dependent
on the speciﬁc plasticity of the endothelial cell population
in muscle. Endothelial cells are heterogeneous, with spe-
cialized properties depending on the organ they reside in
and their order in the vascular tree. For instance, angio-
genesis is induced during a variety of pathologies, but
during physiological conditions in adults it is only pro-
voked in ovaries (during ovarian cycling), in the placenta
(during placental development), and in muscles (during
exercise) (40). Mechanical stretch and increased vessel
wall tension during exercise is reported to result in
increased capillary supply due to increased local levels of
vascular endothelial growth factor (VEGF), hypoxia-in-
ducible factor-1, and matrix metalloproteinase-2 (41).
Thus, a clear difference between striated muscle and other
implantation sites investigated for islet vascular densities
is that muscle endothelium is programmed to proliferate
during muscle overload and concomitant hypoxia (40).
It has recently been reported that leukocytes contribute
to angiogenesis occurring during remodeling and healing
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FIG. 5. Higher vessel densities in transplanted islets compared with adjacent muscle in pancreatectomized patients. Axial images of the forearm
in three different subjects after islet transplantation (white arrows mark islet grafts). A and B: Subject 1. A: Postcontrast. B: The corresponding
plasma volume map calculated from the ﬁrst pass response. The bright spot in B is a superﬁcial vein showing very high blood volume. C and D:
Subject 2. C: Postcontrast. D: The corresponding plasma volume map. The increased plasma volume in the islet grafts compared with the
surrounding muscular tissue in subjects 1 and 2 are visualized through brighter color markings corresponding to the position of the islets. E and
F: Two slices from the high-resolution acquisition of subject 3; note the multiple islet grafts. The graft indicated by the red arrow has a diameter
of 2.4 mm. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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to recruit leukocytes (43,44) and might account for the
leukocyte–endothelial cell interactions observed early af-
ter islet implantation in this study but not after sham
injections. The number of recruited leukocytes decreased
with time after transplantation, which parallels islet revas-
cularization and associated reduced hypoxia (45). No
revascularization of islets 3–5 days after transplantation
could be detected when Gr-1–positive leukocytes had been
depleted in recipients, indicating a crucial role of these
cells in the angiogenic switch. Gr-1 is reported to be
expressed on neutrophils as well as inﬂammatory mono-
cytes but not on the monocyte population involved in
tissue repair (20,42,46). The Gr-1–positive leukocytes re-
cruited to the site of engraftment in the current study that
were responsible for initiation of revascularization are
therefore most likely neutrophils, while the Gr-1–negative
monocyte population that has been shown to be involved
in tissue remodeling (21) and tumor angiogenesis (42)
does not seem to contribute at these early time points. The
mechanism by which neutrophils induce angiogenesis
might be release of VEGF—either from intracellular stor-
ages or through secretion of matrix metalloproteinase-9,
which has been shown to contribute to angiogenesis
through digestion of extracellular matrix and release of
immobilized VEGF (42).
This study presents a novel paradigm for islet transplan-
tation whereby neutrophils recruited to the site for en-
graftment were crucial for the functionally restored
intraislet blood perfusion following transplantation to
striated muscle. In the clinical setting, this site proved to
promote islet revascularization and also permitted longi-
tudinal graft monitoring by high-resolution magnetic res-
onance imaging.
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